dihydrocodeine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Acosta-Mena, D; Adderley, NJ; Anand, A; Bhala, N; Buckley, CD; Byne, N; Chandan, JS; Cooper, J; Denniston, AK; Dhalla, S; Gokhale, KM; Haroon, S; Lord, J; Nirantharakumar, K; Okoth, KO; Raza, K; Sainsbury, C; Subramanian, A; Taverner, T; Thayakaran, R; Thomas, GN; Thomas, T; Wang, J; Zemedikun, DT | 1 |
1 other study(ies) available for dihydrocodeine and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID-19.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Cause of Death; Codeine; COVID-19; Disease Susceptibility; Drug Combinations; Female; Humans; Incidence; Male; Middle Aged; Mortality; Osteoarthritis; Primary Health Care; Propensity Score; Proportional Hazards Models; Risk Factors; SARS-CoV-2; United Kingdom | 2021 |